NNOX Jan 2025 22.500 call
| Previous close | 0.5100 |
| Open | 0.5100 |
| Bid | 0.3000 |
| Ask | 0.6500 |
| Strike | 22.50 |
| Expiry date | 2025-01-17 |
| Day's range | 0.5100 - 0.5100 |
| Contract range | N/A |
| Volume | |
| Open interest | 146 |
GlobeNewswireNanox to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 in September
NEVE ILAN, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced its participation in the Cantor Fitzgerald Global Healthcare Conference 2023, which will be held on September 26-28, 2023 at the InterContinental Barclay Hotel in New York City. Nanox’s Chief Executive Officer, Erez Meltzer, and Chief Financial Officer, Ran Daniel, will engage in a fireside chat and host investor 1x1
Motley Fool3 Magnificent Growth Stocks to Buy on the Dip
Growth stocks have lost momentum in August after a strong start to the year. Innovative companies in the fields of drug development and medical imaging, such as Agenus (NASDAQ: AGEN), BioCryst Pharmaceuticals (NASDAQ: BCRX), and Nano-X Imaging (NASDAQ: NNOX) have all experienced a significant drop in their stock prices in the past 30 days.
Simply Wall St.Nano-X Imaging Second Quarter 2023 Earnings: Misses Expectations
Nano-X Imaging ( NASDAQ:NNOX ) Second Quarter 2023 Results Key Financial Results Net loss: US$17.4m (loss narrowed by...
